Antibiotic abuse leads to increased bacterial resistance,
and the
surviving planktonic bacteria aggregate and secrete extracellular
polymers to form biofilms. Conventional antibacterial agents find
it difficult to penetrate the biofilm, remove the bacteria wrapped
in it, and produce an excellent therapeutic effect. In this study,
a dual pH- and NIR-responsive nanocomposite (A-Ca@PDA) was developed
to remove drug-resistant bacteria through a cascade of catalytic nitric
oxide (NO) release and photothermal clearance. NO can melt in the
outer package of the biofilm, facilitating the nanocomposites to have
better permeability. Thermal therapy further inhibits the growth of
planktonic bacteria. The locally generated high temperature and the
burst release of NO together aggravate the biofilm collapse and bacterial
death after NIR irradiation. The nanocomposites achieved a remarkable
photothermal conversion efficiency of 47.5%, thereby exhibiting significant
advancements in energy conversion. The nanocomposites exhibited remarkable
efficacy in inhibiting multidrug-resistant (MDR) Escherichia
coli and MDR Staphylococcus aureus, thus
achieving an inhibition rate of >90%. Moreover, these nanocomposites
significantly improved the wound-healing process in the MDR S. aureus-infected mice. Thus, this novel nanocomposite
offers a novel strategy to combat drug-resistant bacterial infections.